{{DISPLAYTITLE:Indium (<sup>111</sup>In) igovomab}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458273495
| IUPAC_name =  
| image =  
| drug_name = Indium (<sup>111</sup>In) igovomab
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = F(ab')2
| source = o
| target = [[CA-125]]
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 171656-50-1
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}

'''Indium (<sup>111</sup>In) igovomab''' (trade name '''Indimacis-125''') was a [[mouse]] [[monoclonal antibody]] for the diagnosis of [[ovarian cancer]].{{fact|date=March 2012}}

Linked to the [[chelating agent]] [[DTPA]] and labelled with [[Indium-111]], it was used for imaging (radio-immuno [[scintigraphy]]) of the cancer.{{fact|date=March 2012}} The drug is no longer available.<ref>[https://books.google.com/books?id=ByHccWJfuhMC&pg=RA1-PA1141&lpg=RA1-PA1141&dq=igovomab&source=bl&ots=Q_7tCIaT4H&sig=VK3T-nB8UQ5AWZhmvYjf42EDUvk&hl=de&ei=aa27SveNBJOf_AbDhdmUDQ&sa=X&oi=book_result&ct=result&resnum=11#v=onepage&q=igovomab&f=false Google books: Handbook of Therapeutic Antibodies, vol. 3]</ref><ref>[http://www.biopharma.com/Samples/294.html Biopharma: indium (111 In) igovomab - Indimacis 125]</ref>

==References==
{{reflist}}

{{Monoclonals for tumors}}

[[Category:Monoclonal antibodies for tumors]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}